Imfinzi-based regimens deliver major survival gains in muscle-invasive bladder cancer
The study has shown that perioperative treatment with Imfinzi (durvalumab), alone or in combination with other immunotherapy agents
The study has shown that perioperative treatment with Imfinzi (durvalumab), alone or in combination with other immunotherapy agents
Highlighting KEYTRUDA & expanding cancer pipeline
Nearly one in five women worldwide are now living with obesity
The decision marks a significant expansion for Pfizer’s once-weekly injectable therapy
Industry veteran to lead Brinton’s expansion across India and key Asia Pacific markets
Mumbai event on June 24–25 will spotlight real-world impact of pharmacovigilance beyond AI adoption
Former DCGI and now advisor to UP CM highlights medical device growth, healthcare expansion, and investment opportunities in the state
NEJM study shows strong protection across strains
The standout story remains Wegovy, particularly its new oral formulation
Subscribe To Our Newsletter & Stay Updated